Pharmafile Logo
Pharmafocus logo
Advanced Search

First UK Lassa fever death in over a decade

February 14, 2022
Sales and Marketing

A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …

News

Risk of new heart problems raised after COVID-19

February 11, 2022
Medical Communications

A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …

News

Novavax COVID-19 vaccine meets trial endpoints

February 11, 2022
Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …

News

Sickest patients face record long waits for hospital bed

February 11, 2022
Medical Communications

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …

News

Researchers find molecular treatment works against metastatic cancer spread to the brain

February 11, 2022
Medical Communications

According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …

News

First biologic medicine approved in China for lupus

February 10, 2022
Business Services

Nearly half a million people in China have systematic lupus erythematosus (SLE), and more than have of this number will …

News

COVID-19 isolation law could end this month in England

February 10, 2022
Business Services

Boris Johnson has said that all remaining COVID-19 restrictions in England – including the legal rule to self-isolate – could …

News

AI support tool aims to change skin cancer treatment in the NHS

February 10, 2022
Business Services

Chelsea and Westminster Hospital NHS Foundation Trust has announced the expansion of its partnership with Skin Analytics, with the roll …

News

FDA accepts Dupixent (dupilumab) for children with moderate-to-severe atopic dermatitis

February 10, 2022
Business Services

The FDA has accepted the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for children aged six months to five …

News

FDA investigate possible increased risk of death with lymphoma medicine

February 9, 2022
Research and Development

The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …

News

SaNOtize breakthrough treatment 99% effective against COVID-19

February 9, 2022
Research and Development

SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …

News

Despite persistent need, J&J halts COVID-19 vaccine output

February 9, 2022
Research and Development

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …

News

NHS waiting-list backlog will take years to clear, ministers say

February 9, 2022

Ministers say that the waiting list for hospital treatment will not start falling for two years, in spite of unveiling …

News

Thermo Fisher Scientific partners with Medidata Acorn AI for clinical research advancement

February 8, 2022
Manufacturing and Production

Thermo Fisher Scientific has announced a multiyear partnership with medidata Acorn AI, a Dassault Systemes company leading the digital transformation …

News

Thousands with advanced prostate cancer to benefit from drug approval

February 8, 2022
Manufacturing and Production

Astellas has announced that the SMC has accepted the use of XTANDIâ„¢ (enzalutamide) to treat patients with metastatic hormone-sensitive prostate …

News

SMC approves diroximel fumarate as multiple sclerosis treatment

February 8, 2022
Manufacturing and Production

The SMC has approved VUMERITY (diroximel fumarate), a next-generation oral fumarate for the treatment of adults living with relapsing-remitting multiple …

News

First immunotherapy to treat advanced endometrial cancer on the NHS via Cancer Drugs Fund

February 8, 2022
Manufacturing and Production

GSK has shared that NICE is to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via …

News
fejiomfxwaeana8

First gene therapy for rare genetic neurodegenerative disorder in children

February 7, 2022
Sales and Marketing

NICE has published a draft highly specialised technologies guidance, recommending gene therapy atidarsagene autotemcel for some children with the rare, …

News

NICE approves new treatment for chronic heart failure

February 7, 2022
Sales and Marketing

Empagliflozin (Jardiance®) has received a positive NICE recommendation for the treatment of chronic heart failure. NICE has announced that empagliflozin …

News

NICE recommends new combination for untreated advanced kidney cancer

February 4, 2022
Medical Communications

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026